Skip to main content

SKNY · LIR Life Sciences Corp. · Financials

0.1400 CAD -0.0150 (-9.68%) At close · Nov 5 Intraday price with Plus
Market Cap
4.01M CAD
Shares
28.67M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Net Income
-3.9M -820%
FY2026 Net Income FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025
CAD -3.9M -423.77K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.